Cargando…

Gut Microbiome and Metabonomic Profile Predict Early Remission to Anti-Integrin Therapy in Patients with Moderate to Severe Ulcerative Colitis

Patients with ulcerative colitis (UC) have low response rates to anti-integrin medications, necessitating the identification of noninvasive biomarkers for predicting remission to anti-integrin therapy. In this study, patients with moderate to severe UC commencing anti-integrin therapy (n = 29), inac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jie, Fang, Huaying, Hong, Na, Lv, Chaolan, Zhu, Qihua, Feng, Yinping, Wang, Bo, Tian, Jiashuang, Yu, Yue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269848/ https://www.ncbi.nlm.nih.gov/pubmed/37199618 http://dx.doi.org/10.1128/spectrum.01457-23

Ejemplares similares

Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
por: Feagan, Brian G, et al.
Publicado: (2019)

Ethnicity Associated Microbial and Metabonomic Profiling in Newly Diagnosed Ulcerative Colitis
por: Misra, Ravi, et al.
Publicado: (2022)

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
por: Huang, Chunlan, et al.
Publicado: (2022)

Integration of transcriptomics and metabonomics: improving diagnostics, biomarker identification and phenotyping in ulcerative colitis
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2013)

Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission
por: Li, Zongwei, et al.
Publicado: (2021)

Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individuals
por: Bjerrum, Jacob Tveiten, et al.
Publicado: (2014)

Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis
por: Fang, Jian, et al.
Publicado: (2021)

Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission
por: Głąbska, Dominika, et al.
Publicado: (2020)

Transcriptional Signatures That Define Ulcerative Colitis in Remission
por: Fenton, Christopher G, et al.
Publicado: (2020)

Is Long-Term Therapy With Thiopurines Effective for Maintaining Remission in Patients With Moderate-To-Severe Ulcerative Colitis?
por: Jeon, Seong Ran, et al.
Publicado: (2015)

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis
por: Lichtenstein, Gary R., et al.
Publicado: (2015)

Integrated Metabonomics and Network Pharmacology to Reveal the Action Mechanism Effect of Shaoyao Decoction on Ulcerative Colitis
por: Wu, Jin, et al.
Publicado: (2022)

Advances in gut microbiome in metabonomics perspective: based on bibliometrics methods and visualization analysis
por: Wang, Jieyan, et al.
Publicado: (2023)

Remission of ulcerative colitis flare-up induced by nivolumab
por: Iwamoto, Maho, et al.
Publicado: (2020)

Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission
por: Rooks, Michelle G, et al.
Publicado: (2014)

Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis
por: Yoon, Hyuk
Publicado: (2019)

Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis
por: Cortez, Ramon V., et al.
Publicado: (2021)

Impact of gut Microbiome alteration in Ulcerative Colitis patients on disease severity and outcome
por: Basha, Osama Mohammed, et al.
Publicado: (2022)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
por: Pop, Corina Silvia, et al.
Publicado: (2020)

Rapid Induction and Maintenance of Remission in Refractory Ulcerative Colitis with Ustekinumab
por: Chen, An-Yu, et al.
Publicado: (2019)

Real-life evaluation of histologic scores for Ulcerative Colitis in remission
por: Arkteg, Christian Børde, et al.
Publicado: (2021)

Analysis of Endoscopic Evaluation Reliability for Ulcerative Colitis in Histological Remission
por: Kanazawa, Mimari, et al.
Publicado: (2021)

Moderating Gut Microbiome/Mitochondrial Axis in Oxazolone Induced Ulcerative Colitis: The Evolving Role of β-Glucan and/or, Aldose Reductase Inhibitor, Fidarestat
por: El-Deeb, Omnia Safwat, et al.
Publicado: (2023)

Imbalanced mucosal microcirculation in the remission stage of ulcerative colitis using probe-based confocal laser endomicroscopy
por: Tian, Yu, et al.
Publicado: (2019)

Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis
por: Haga, Keiichi, et al.
Publicado: (2022)

Interference with the lower gut–liver axis induces remission of primary sclerosing cholangitis in a patient with ulcerative colitis
por: Ong, John, et al.
Publicado: (2018)

Capsulized Fecal Microbiota Transplantation Induces Remission in Patients with Ulcerative Colitis by Gut Microbial Colonization and Metabolite Regulation
por: Chen, Qiongyun, et al.
Publicado: (2023)

Deep Remission With Vedolizumab in Patients With Moderately to Severely Active Ulcerative Colitis: A GEMINI 1 post hoc Analysis
por: Sandborn, William J, et al.
Publicado: (2019)

Fecal Filobasidium Is Associated with Clinical Remission and Endoscopic Response following Fecal Microbiota Transplantation in Mild-to-Moderate Ulcerative Colitis
por: van Thiel, Isabelle A. M., et al.
Publicado: (2022)

Exploring Disease Remission and Bowel Urgency Severity Among Adults with Moderate to Severe Ulcerative Colitis: A Qualitative Study
por: Dubinsky, Marla C, et al.
Publicado: (2022)

Dynamic Changes in Gut Microbiome of Ulcerative Colitis: Initial Study from Animal Model
por: Gu, Wenchao, et al.
Publicado: (2022)

A systematic review and meta-analysis of artificial intelligence-diagnosed endoscopic remission in ulcerative colitis
por: Lv, Bing, et al.
Publicado: (2023)

Association of endoscopic and histological remission with clinical course in patients of ulcerative colitis
por: Narang, Vikram, et al.
Publicado: (2018)

Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2018)

Tofacitinib for induction of remission in ulcerative colitis: systematic review and meta-analysis
por: Paschos, Paschalis, et al.
Publicado: (2018)

Potential benefits of immunomodulator use with vedolizumab for maintenance of remission in ulcerative colitis
por: Naganuma, Makoto, et al.
Publicado: (2021)

Memory T Cell Subpopulations as Early Predictors of Remission to Vedolizumab in Ulcerative Colitis
por: Gonzalez-Vivo, Maria, et al.
Publicado: (2022)

Sleep Deficiency Is Associated With Exacerbation of Symptoms and Impairment of Anorectal and Autonomic Functions in Patients With Functional Constipation
por: Liu, Jie, et al.
Publicado: (2022)

Slow, deep breathing intervention improved symptoms and altered rectal sensitivity in patients with constipation-predominant irritable bowel syndrome
por: Liu, Jie, et al.
Publicado: (2022)

Complexities of the Microbiome: Jaundice in Patient With Ulcerative Colitis
por: Kelly, Nicole
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j0sssfttaqpu30m8k326a16fvv